Sunday, August 30, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • UP InternationalTrade Show
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • UP InternationalTrade Show
Fiinews
No Result
View All Result
Home Manufacturing

India urged to be a world leader in pharma supplies

Fiinews by Fiinews
March 25, 2020
in Manufacturing
Reading Time: 2 mins read
A A
0
Pfizer
0
SHARES
11
VIEWS
LinkedinShare on Twitter

Threat of over dependence on China, warns Sridhar

India needs to be a World leader for not just Generic formulations but APIs (active pharmaceutical ingredients) too, according to S Sridhar, Chair, FICCI Pharmaceuticals Committee and MD, Pfizer.

India’s pharmaceutical import dependence on China, nearly 70% by value, has become a significant threat to the local healthcare manufacturing and global supply chain, Sridhar warned in a message welcoming the Government’s decision on Bulk Drug Parks.

While Indian pharma companies over years have climbed up the value chain to focus on value-added formulations, but this over dependence on China has increased the threat to the nation’s health security as some of these critical and complex APIs are crucial to address India’s growing disease burden.

India should not look at these Bulk Drug Parks only for Domestic requirement. China became big supplier because of scale which looked into both domestic and export requirement, he pointed out.

“Domestic (market) will not give scale and is always exposed to cost and pricing pressures. With this new policy initiative, the Government must look at incentivising the manufacturing of the critical 54 APIs which were recently restricted for exports,” he said on 22 Mar 2020.

He called on the Government and the Industry to work together for not just domestic capacities but fulfilling global export demands too.

The Indian pharma industry has been a world leader in generics markets contributing significantly to the global demand for generics in terms of volume.

‘Made in India’ drugs supplied to the developed economies such as the US, EU, Japan and many other countries are known for their safety and quality, he noted.

The Government is promoting Bulk Drug Parks for financing Common Infrastructure facilities in 3 Bulk Drug Parks with financial implication of Rs.3,000 crore over next 5 years to boost domestic manufacturing of critical KSMs/Drug Intermediates and APIs.

Welcoming the Government decision, he assured wide support from FICCI and its pharma member companies. fiinews.com

Tags: FICCIPfizer
ShareTweetShare

Related Posts

STL
Manufacturing

Manufacturing: STL heads for Net-Zero ambitions

by Fiinews
August 28, 2026
0
16

100% Green Hydrogen integrated into glass manufacturing operations STL (NSE: STLTECH), a leading connectivity solutions provider for AI-ready digital infrastructure,...

PIB
Manufacturing

Manufacturing: Jabalpur to overhaul 80 tanks/year

by Fiinews
August 28, 2026
0
18

Defence Minister highlights the need to equip tanks with superior sensors and capabilities aligned with modern battlefield requirements A new...

PIB

Manufacture: Tokyo given Semicons-AI highlights

August 27, 2026
18
CII

Manufacture: Need healthcare medical technology

August 26, 2026
20
PIB

Manufacture: DST funds tissue engineering project

August 21, 2026
21
Rolls Royce

Manufacture: Reliance-Rolls Royce to make engine

August 18, 2026
38
SBI YONO
Upits 2026 brochure 062026 pdf

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Investment: India welcomes US investment and technology collaboration

    0 shares
    Share 0 Tweet 0
  • Market: PM Modi-President Zelenskyy discussed trade and technology

    0 shares
    Share 0 Tweet 0
  • Manufacturing: Approved ‘BioE3’of Biotechnology Dept

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Export: India-Argentina trade crossed $6.5bn
  • Tender: Foundation stone laid for Rs.1,503.5 roads
  • Market: Coforge-Pegasystems to work globally
  • Project: REPLUS works on next phase of BESS
  • Export: Reforms simplify SOP and OGEL framework

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • UP International

© 2024 FIINEWS - Design and developed by 7clicksmedia.